March 28, 2016

I-STOP Legislation Takes Effect in New York, Spurs Provider eRx and EPCS Adoption

Electronic prescribing is a first line defense for combating rampant prescription fraud and abuse in the nation today. And in New York, both prescribers and pharmacies have embraced its capabilities in order to make a difference in the fight against opioid abuse while ensuring patient safety and privacy, care quality, and process efficiency remain at the forefront.

A year after New York delayed its enforcement deadline for I-STOP – legislation that requires all prescriptions in the state, including controlled substances, to be transmitted electronically – the mandate has officially taken effect. On the pharmacy side, 95 percent of pharmacies in New York are ready and able to accept electronic prescriptions for controlled substances. Meanwhile, the state’s providers have done a tremendous job stepping up to the plate, with the number of prescribers enabled for electronic prescribing of controlled substances (EPCS) skyrocketing by an impressive 28 percent since February, with more than 47 percent of providers in the state now ready for EPCS. Put another way, 68 percent of active e-prescribers in New York are also enabled for EPCS, which significantly outpaces the national average of 14 percent nearly five times over. And even more impressive is that those providers who are enabled are actively utilizing the technology, with 37 percent of all EPCS transactions nationwide coming from New York.

In response to I-STOP – and the need to combat the country’s opioid abuse epidemic – the recent rise in EPCS enablement has been made possible because of EHR vendors’ certification of the technology, which is a necessity in order for prescribers to use the technology. Currently, EHRs serving 96 percent of prescribers in New York are certified for EPCS.

As we look beyond New York, there seems to be misinformation and confusion contributing to the slow rate of adoption nationwide. We are often asked to explain both the process for becoming enabled and the technology requirements, including necessary software updates and DEA third-party audits for vendors. But becoming EPCS enabled is much simpler than many might think. Providers can find step-by-step instructions at getEPCS.com, including information on required EHR software updates, prescriber ID proofing, credentialing for secure two-factor authentication, and setting secure access controls.

In 2015, we achieved two major milestones in the fight against prescription fraud and abuse, first with EPCS becoming legal nationwide, and second with the implementation of New York’s legislation.  But there is more work to be done to address this nationwide epidemic. Patient safety, public health and prescriber efficiency must continue to be the primary drivers of technology adoption, and New York’s strong push for e-prescribing and EPCS enablement over the past year can and should be looked at as a case study of success for the rest of the country to follow.

Please visit getEPCS.com for more information and be sure to follow @Surescripts for the latest news, updates and educational resources on e-prescribing and EPCS adoption.

NY-EPCS-I-Stop_LI-Pub_700x400

YOU MIGHT ALSO LIKE

July 05, 2018

Key Technologies for Fighting Opioid Misuse are Gaining Traction

The statistics are staggering. According to the Centers for Disease Control and Prevention, the opioid epidemic now takes more lives in the U.S. than breast cancer. In addition, American life expectancy at birth declined for the second consecutive year in 2016 due to a dramatic 21 percent rise in the death rate from drug overdoses. Our nation has not experienced a two-year consecutive decline in life expectancy since the early 1960s as a result of an influenza epidemic. Even the worst mortality rate of the AIDS epidemic in 1993 caused American life expectancy to drop for just one year. Read more...

July 02, 2018

Maine Required E-Prescribing for Opioids Last Year—and the Results Are In

This time last year, Maine implemented legislation that requires electronic prescribing for opioids. At the time, Maine ranked 25th in the nation based on prescriber and pharmacist enablement and utilization of the technology, known as E-Prescribing for Controlled Substances (EPCS). Now the state is ranked third in the nation, with virtually all its pharmacies and more than half of all its prescribers enabled for the technology as of May 2018. New York leads the nation, having implemented a legislative requirement in 2016 that requires all prescriptions to be delivered electronically, including controlled substances. Read more...

June 20, 2018

Surescripts Supports Healthcare Leadership Council’s “Roadmap for Action” to Address Opioid Crisis

Today, Surescripts joined more than 70 healthcare organizations in supporting the Healthcare Leadership Council’s “Roadmap for Action” offering guidance for healthcare professionals, lawmakers and regulators to address the opioid crisis. Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX